NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.45
-0.74 (-5.21%)
At close: Jan 23, 2026, 4:00 PM EST
13.30
-0.15 (-1.12%)
After-hours: Jan 23, 2026, 7:46 PM EST

NovoCure Revenue

NovoCure had revenue of $158.81M in the quarter ending June 30, 2025, with 5.62% growth. This brings the company's revenue in the last twelve months to $630.16M, up 14.58% year-over-year. In the year 2024, NovoCure had annual revenue of $605.22M with 18.82% growth.

Revenue (ttm)
$630.16M
Revenue Growth
+14.58%
P/S Ratio
2.31
Revenue / Employee
$431,632
Employees
1,488
Market Cap
1.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024605.22M95.88M18.82%
Dec 31, 2023509.34M-28.50M-5.30%
Dec 31, 2022537.84M2.81M0.53%
Dec 31, 2021535.03M40.67M8.23%
Dec 31, 2020494.37M143.05M40.72%
Dec 31, 2019351.32M103.25M41.62%
Dec 31, 2018248.07M71.04M40.13%
Dec 31, 2017177.03M94.14M113.57%
Dec 31, 201682.89M49.80M150.52%
Dec 31, 201533.09M17.60M113.60%
Dec 31, 201415.49M5.13M49.53%
Dec 31, 201310.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AdaptHealth3.26B
QuidelOrtho2.71B
Enovis2.23B
CONMED1.35B
Tandem Diabetes Care1.01B
UFP Technologies597.95M
PROCEPT BioRobotics299.91M
Axogen214.71M
Revenue Rankings